← Back to headlines
Biogen Acquires Apellis for $5.6 Billion to Enhance Rare Disease Pipeline
Biogen has announced the acquisition of Apellis for $5.6 billion, a move aimed at strengthening its pipeline for rare disease treatments.
1 Apr, 11:36 — 1 Apr, 11:36
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Farmers' Group Criticizes Proposed Pax Silica Economic Zone in Philippines
just now
Philippine President Marcos Orders P17.27 Billion for Classroom Construction
just now
Philippine President Marcos Pushes P46.22 Billion for Infrastructure Projects
just now